# US 2018/0021348 A1 · Hypotensive lipid-containing biodegradable intraocular implants and related implants

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0021348 A1
- Document ID: US20180021348A1
- Status: Published application
- Kind: A1
- Application number: 15/722,205
- Filed: 2017-10-02
- Published: 2018-01-25
- Earliest claimed: 2004-04-30
- Assignees: Allergan, Inc.
- Applicants: Allergan, Inc.
- Inventors: Patrick M. Hughes
- Web page: https://patentgrep.com/patent/US20180021348A1

## CPC

- A61K 31/5575: having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A61F 9/0017: {implantable in, or in contact with, the eye, e.g. ocular inserts}
- A61K 9/0048: {Eye, e.g. artificial tears}
- A61K 9/0051: {Ocular inserts or implants}
- A61K 9/1647: {Polyesters, e.g. poly(lactide-co-glycolide)}
- A61K 31/16: Amides, e.g. hydroxamic acids
- A61K 47/34: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

Biocompatible intraocular implants include a prostamide component and a biodegradable polymer that is effective in facilitating release of the prostamide component into an eye for an extended period of time. The prostamide component may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The Implants may be placed in an eye to treat or reduce a at least one symptom of an ocular condition, such as glaucoma.

## Claims

### Claim at position 1

-48. (canceled)

### Claim 49

A method of treating glaucoma, the method comprising placing a biodegradable intraocular implant into the anterior chamber of an eye of a patient in need thereof, the implant comprising bimatoprost or a pharmaceutically acceptable salt thereof and a biodegradable polymer matrix that releases an amount of the bimatoprost or a pharmaceutically acceptable salt thereof from the implant effective to reduce at least one symptom of glaucoma, wherein the amount of the bimatoprost or a pharmaceutically acceptable salt thereof is released into the eye for a period of time greater than about one week after the implant is placed into the anterior chamber of the eye.

### Claim 50 (depends on 49)

The method of claim 49, wherein the symptom is increased intraocular pressure in the eye.

### Claim 51 (depends on 49)

The method of claim 49, wherein the biodegradable polymer matrix comprises a polylactic acid polymer.

### Claim 52 (depends on 51)

The method of claim 51, wherein the biodegradable polymer matrix further comprises a polylactic acid polyglycolic acid copolymer.

### Claim 53 (depends on 52)

The method of claim 52, wherein the method is effective in maintaining the intraocular pressure in the eye at a reduced level.

### Claim 54 (depends on 52)

The method of claim 52, wherein the method is effective in reducing intraocular pressure in the eye.

### Claim 55 (depends on 50)

The method of claim 50, wherein the implant is injected into the anterior chamber of the patient with a needle.

### Claim 56 (depends on 54)

The method of claim 54, wherein the implant is injected into the anterior chamber of the patient with a needle.
